Indications |
Oral Advanced or locally advanced breast cancer Adult: In women who are no longer responsive to anti-oestrogen therapy: 25 mg once daily. |
Contraindications |
Hypersensitivity. Premenopausal women. Pregnancy and lactation. |
Warnings / Precautions |
Hepatic and renal impairment. Monitor bone mineral density at regular intervals especially in patients at risk of osteoporosis. |
Adverse Reactions |
Hot flushes; nausea; fatigue; increased sweating; dizziness; headache; insomnia; skin rash; abdominal pain; anorexia, vomiting (less frequently), dyspepsia, depression, alopoecia, peripheral oedema, constipation, dyspepsia. Rarely thrombocytopaenia, leucopaenia. |
Drug Interactions |
May result in reduced plasma levels of exemestane when used with CYP3A4 enzyme inducers. Oestrogen-containing drugs; St. John's wort, black cohosh, dong quai. See Below for More exemestane Drug Interactions |
Mechanism of Actions |
Exemestane is an irreversible selective aromatase inhibitor which acts as a false substrate for the aromatase enzyme, forming an intermediate that binds irreversibly to the active site causing its inactivation. It also lowers circulating oestrogens in estrogen-dependent breast carcinoma. Absorption: Rapidly absorbed. Distribution: Widely distributed and extensively bound to plasma proteins. Metabolism: Metabolised via oxidation by CYP3A4, and via reduction by aldoketoreductase Excretion: Metabolites are excreted in urine and faeces, less than 1% excreted unchanged in the urine. |
Administration |
Should be taken with food. (Take after a meal.) |
ATC Classification |
L02BG06 - exemestane ; Belongs to the class of enzyme inhibitors. Used in endocrine therapy. |
Available As |
|
Exemstane
Post Review about Exemstane Click here to cancel reply.
Exemstane Containing Brands
Exemstane is used in following diseases
Drug - Drug Interactions of Exemstane
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.